Clinical Trial Update: Randomized Clinical Trial of Adipose-Derived Stem Cells in the Treatment of Pts With ST-elevation Myocardial Infarction [Phase 1]

View source ↗

Summary

A Phase 1 randomized trial testing adipose-derived stem cells in ST-elevation myocardial infarction has completed, reporting safety and feasibility results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Myocardial Infarction

Drugs mentioned

• Adipose-Derived Stem Cells (adipose-derived stem cells)

Snippet

Sponsor: Cytori Therapeutics | Conditions: Myocardial Infarction, Coronary Arteriosclerosis | Phase 1 | Status: COMPLETED